zoledronic acid has been researched along with Granulomatosis, Lipid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iiri, T; Makita, N; Manaka, K | 1 |
| Ea, HK; Paycha, F; Poiroux, L; Polivka, M | 1 |
| Massey, HD; Roberts, WN; Srikulmontree, T | 1 |
1 review(s) available for zoledronic acid and Granulomatosis, Lipid
| Article | Year |
|---|---|
Erdheim-Chester disease and pituitary involvement: a unique case and the literature.
Topics: Adult; Bisphosphonate-Associated Osteonecrosis of the Jaw; Congenital Hypothyroidism; Diabetes Insipidus, Neurogenic; Diphosphonates; Erdheim-Chester Disease; Humans; Hypopituitarism; Hypothyroidism; Imidazoles; Interferon-alpha; Magnetic Resonance Imaging; Male; Pituitary Gland; Pituitary Gland, Anterior; Thyrotropin; Zoledronic Acid | 2014 |
2 other study(ies) available for zoledronic acid and Granulomatosis, Lipid
| Article | Year |
|---|---|
Efficacy of zoledronic acid in Erdheim-Chester disease: A case report.
Topics: Aged; Bone Density Conservation Agents; Bone Diseases; Breast Neoplasms; Diphosphonates; Erdheim-Chester Disease; Female; Follow-Up Studies; Humans; Imidazoles; Zoledronic Acid | 2016 |
Treatment of skeletal Erdheim-Chester disease with zoledronic acid: case report and proposed mechanisms of action.
Topics: Bone Density Conservation Agents; Diphosphonates; Erdheim-Chester Disease; Female; Humans; Imidazoles; Middle Aged; Zoledronic Acid | 2007 |